Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US Adults.

Kendra D Sims Pengxiao Carol WeiJoanne M PenkoSusan HennessyPamela G CoxsonNita H Mukand Brandon K Bellows Dhruv S Kazi Yiyi ZhangRoss BoylanAndrew E Moran Kirsten Bibbins

Published in: Hypertension (Dallas, Tex. : 1979) (2024)

Among low-risk adults with stage 1 hypertension, substantial benefits to cardiovascular health could be achieved through public policy that promotes the adoption of nonpharmacologic therapy.

Keyphrases

blood pressure
healthcare
mental health
public health
climate change
electronic health record
stem cells
emergency department
adverse drug